Status:
COMPLETED
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer
Lead Sponsor:
Eli Lilly and Company
Conditions:
Carcinoma, Non Small Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed non small cell lung cancer
- No prior chemotherapy or radiation for non small cell lung cancer
- No prior malignancy
Exclusion
- Pregnancy or breastfeeding
- Serious concomitant disorders
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00191256
Start Date
June 1 2001
End Date
July 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chapel Hill, North Carolina, United States